Physiological Responses to Maximal 4-s Sprint Interval Cycling
NCT ID: NCT04448925
Last Updated: 2020-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2019-01-10
2020-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Including Sprints During Low-intensity Cycling Exercises on Performance and Muscle/Blood Characteristics
NCT04640883
Effects of Intermittent Pneumatic Compression on Recovery of Cyclists
NCT06815640
Stressors and Recovery Regulation on the Super-compensation Effect
NCT06295016
Recovery Kinetics After Different Sprint Training Protocols (STRecovery)
NCT04766411
Recovery Following Acute Endurance Training
NCT06043492
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Overview. A randomized, cross-over experimental design was conducted. Each participant visited the laboratory on four occasions which were separated by two to five days. Measurement of body mass, familiarization with experimental procedures and cycling peak oxygen consumption test (VO2peak) were performed on the first visit. Participants took part in inertial-load exercise (ILE) on the remaining test days. On each separate session, a different inter-sprint recovery duration was employed (i.e. 15, 30 or 45-s). Cycling power output, pulmonary gas exchange, vastus lateralis de-oxygenation status, heart rate and blood lactate were measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recovery duration 15 seconds
Resting for 15 sec
inertial-load exercise (ILE)
Length of time between exercise bouts
Recovery duration 30 seconds
Resting for 30 sec
inertial-load exercise (ILE)
Length of time between exercise bouts
Recovery duration 45 seconds
Resting for 45 sec
inertial-load exercise (ILE)
Length of time between exercise bouts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inertial-load exercise (ILE)
Length of time between exercise bouts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas at Austin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas at Austin Human Performance Laboratory
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vardarli E, Satiroglu R, Allen JR, Bjellquist-Ledger R, Burton HM, Coyle EF. Physiological responses to maximal 4 s sprint interval cycling using inertial loading: the influence of inter-sprint recovery duration. Eur J Appl Physiol. 2021 Aug;121(8):2295-2304. doi: 10.1007/s00421-021-04677-6. Epub 2021 May 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UTexasAustinHPL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.